A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Pergolide
Secukinumab
The metabolism of Secukinumab can be increased when combined with Bosutinib.
Pergolide
Certolizumab pegol
The metabolism of Certolizumab pegol can be increased when combined with Bosutinib.
Pergolide
Golimumab
The metabolism of Golimumab can be increased when combined with Bosutinib.
Pergolide
Rilonacept
The metabolism of Bosutinib can be increased when combined with Rilonacept.
Pergolide
Tocilizumab
The metabolism of Bosutinib can be increased when combined with Tocilizumab.
Pergolide
Canakinumab
The metabolism of Bosutinib can be increased when combined with Canakinumab.
Pergolide
Afelimomab
The metabolism of Bosutinib can be increased when combined with Afelimomab.
Pergolide
Abatacept
The metabolism of Bosutinib can be increased when combined with Abatacept.
Pergolide
Cyclopenthiazide
The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclopenthiazide is combined with Bosutinib.
Pergolide
Mebutizide
The risk or severity of neutropenia and thrombocytopenia can be increased when Mebutizide is combined with Bosutinib.
Pergolide
Reviparin
The risk or severity of bleeding can be increased when Reviparin is combined with Bosutinib.
Pergolide
Troxerutin
The risk or severity of bleeding can be increased when Troxerutin is combined with Bosutinib.
Pergolide
Clorindione
The risk or severity of bleeding can be increased when Clorindione is combined with Bosutinib.
Pergolide
Fluindione
The risk or severity of bleeding can be increased when Fluindione is combined with Bosutinib.
Pergolide
4-hydroxycoumarin
The risk or severity of bleeding can be increased when 4-hydroxycoumarin is combined with Bosutinib.
Pergolide
Diphenadione
The risk or severity of bleeding can be increased when Diphenadione is combined with Bosutinib.
Pergolide
Ethyl biscoumacetate
The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Bosutinib.
Pergolide
Dabigatran
The risk or severity of bleeding can be increased when Dabigatran is combined with Bosutinib.
Pergolide
Edetate calcium disodium anhydrous
The risk or severity of bleeding can be increased when Edetate calcium disodium anhydrous is combined with Bosutinib.
Pergolide
Tocopherylquinone
The risk or severity of bleeding can be increased when Tocopherylquinone is combined with Bosutinib.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3